Dr John Isaac
Project Lead, Synaptic Health
John is Senior Director in Neuroscience at Johnson & Johnson Innovation. Prior to joining Johnson & Johnson, John was Head of Neuroscience and Mental Health at the Wellcome Trust.
John co-leads two DPUK Work Packages within the Experimental Medicine Incubator's Synaptic Health theme. Those are Work Package 26a: Synaptic loss and its functional consequences in early Alzheimer's disease, using pre-synaptic markers and magnetoencephalography; and Work Package 26b: Synaptic loss and its functional consequences in early Alzheimer's disease, using a new post-synaptic TARP γ8 AMPAR ligand.